Aptose Biosciences Inc APTO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 04/26/24 EDT
1.22quote price arrow up+0.06 (+5.17%)
Volume
104,332
52 week range
1.15 - 8.70
Loading...
  • Open1.21
  • Day High1.27
  • Day Low1.16
  • Prev Close1.16
  • 52 Week High8.70
  • 52 Week High Date05/02/23
  • 52 Week Low1.15
  • 52 Week Low Date04/25/24

Key Stats

  • Market Cap19.176M
  • Shares Out15.72M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta1.35
  • YTD % Change-51.97

KEY STATS

  • Open1.21
  • Day High1.27
  • Day Low1.16
  • Prev Close1.16
  • 52 Week High8.70
  • 52 Week High Date05/02/23
  • 52 Week Low1.15
  • 52 Week Low Date04/25/24
  • Market Cap19.176M
  • Shares Out15.72M
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta1.35
  • YTD % Change-51.97

RATIOS/PROFITABILITY

  • EPS (TTM)-7.77
  • P/E (TTM)-0.16
  • Fwd P/E (NTM)-0.33
  • EBITDA (TTM)-52.268M
  • ROE (TTM)-293.96%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/06/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aptose Biosciences Inc

 

Content From Our Affiliates

Profile

MORE
Aptose Biosciences Inc. is a clinical-stage biotechnology company. The Company is engaged in the development and commercialization of precision medicines addressing unmet clinical needs in oncology, with an initial focus on hematology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities. The Company has two...
William Rice Ph.D.
Chairman of the Board, President, Chief Executive Officer
Fletcher Payne
Chief Financial Officer, Senior Vice President, Chief Business Officer
Address
251 Consumers Rd Suite 1105
North York, ON
M2J 4R3
Canada